MedTrace Logo

Efficacy and Safety of Coronary Amphilimus-ELuting Stent in diAbeTic patiEnts

NCT03651180 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3400

Last updated 2018-08-29

No results posted yet for this study

Summary

More recently a polymer-free drug eluting stent (Amphilimus eluting stent) has shown to have a superiority in terms of efficacy and safety if compared with stable polymer drug eluting stent when used in diabetic patients. However, to date there are no direct comparisons of these two type of drug eluting stents.

Conditions

Sponsors & Collaborators

  • Ospedale S. Giovanni Bosco

    lead OTHER

Principal Investigators

  • Salvatore Colangelo, MD · San Giovanni Bosco Hospital - ASL Città di Torino

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-10-01
Completion
2023-10-01

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651180 on ClinicalTrials.gov